Evidence map›Paper›PMID 42460936›Full record

ArticleJACC. Case reports2026

Atrial Septal Erosion: Very Rare Complication of Percutaneous PFO Closure.

Katarzyna Kozak, Wojciech Kula, Jakub Drozd, Krzysztof Sus, Wojciech Wokurka, Andrzej Glowniak, Mateusz Drozd

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katarzyna KozakDepartment of Cardiology, Hospital of the Ministry of the Interior and Administration, Lublin, Poland. Electronic address: katarzyna.kozak95@gmail.com.
Wojciech KulaDepartment of Cardiology, Hospital of the Ministry of the Interior and Administration, Lublin, Poland.
Jakub DrozdDepartment of Cardiology, Hospital of the Ministry of the Interior and Administration, Lublin, Poland.
Krzysztof SusDepartment of Cardiology, Hospital of the Ministry of the Interior and Administration, Lublin, Poland.
Wojciech WokurkaDepartment of Cardiology, Hospital of the Ministry of the Interior and Administration, Lublin, Poland.
Andrzej GlowniakDepartment of Cardiology, Medical University of Lublin, Lublin, Poland.
Mateusz DrozdMedical University of Gdansk, Gdansk, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPercutaneous patent foramen ovale (PFO) closure is an established method for secondary prevention of paradoxical embolism in patients with cryptogenic stroke. Residual right-to-left shunts after PFO closure are observed in up to 25% of patients. CASE SUMMARY: We present the clinical case of a 56-year-old man with cryptogenic stroke who underwent transcatheter PFO closure. Six months postprocedure, echocardiographic follow-up revealed a progressive residual right-to-left shunt due to marginal septal erosion. A first attempt at transcatheter closure of the residual defect was unsuccessful. Subsequently, a trans-septal puncture with deployment of an overlapping PFO occluder was performed, resulting in complete closure of the residual shunt. DISCUSSION: This case highlights the importance of systematic echocardiographic surveillance and individualized intervention strategies in managing rare device-related complications after PFO closure. TAKE-HOME MESSAGE: Device-related atrial septal erosion is a rare but potentially serious complication, requiring careful assessment and appropriate treatment.

Indexed as

3-dimensional imagingbubble echocardiographycomplicationechocardiographyoccluderstroke

Identifiers

PMID42460936
PMCPMC13379816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.